Chk1 inhibition potentiates the therapeutic efficacy of PARP inhibitor BMN673 in gastric cancer

Globally, gastric cancer is the second leading cause of cancer deaths because of the lack of effective treatments for patients with advanced tumors when curative surgery is not possible. Thus, there is an urgent need to identify molecular targets in gastric cancer that can be used for developing nov...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Cancer Res
Main Authors: Yin, Yuping, Shen, Qian, Zhang, Peng, Tao, Ruikang, Chang, Weilong, Li, Ruidong, Xie, Gengchen, Liu, Weizhen, Zhang, Lihong, Kapoor, Prabodh, Song, Shumei, Ajani, Jaffer, Mills, Gordon B, Chen, Jianying, Tao, Kaixiong, Peng, Guang
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5385637/
https://ncbi.nlm.nih.gov/pubmed/28401005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados